期刊文献+

调脂活血降糖方治疗2型糖尿病合并非酒精性脂肪性肝病30例 被引量:3

Clinical Observation on 30 Cases of Type Ⅱ Diabetes Combined with Non-alcoholic Fatty Liver Diseases Treated by Tiaozhi Huoxue Jiangtang Prescription
下载PDF
导出
摘要 目的:观察调脂活血降糖方治疗2型糖尿病合并非酒精性脂肪性肝病的临床疗效。方法:60例2型糖尿病合并非酒精性脂肪性肝病患者随机分为治疗组和对照组各30例,对照组在饮食和运动治疗的基础上给予口服二甲双胍片0.25g,日3次;治疗组在对照组治疗的基础上加服调脂活血降糖方,日1剂,两组均治疗90d,观察两组患者临床疗效及治疗前后BMI、WHR、AST、ALT、FBG、HbALc、TG、LDL-C、HDL-C的变化情况。结果:治疗组、对照组总有效率分别为93.3%和46.7%,两组疗效比较差异有统计学意义(P<0.01);治疗后治疗组BMI、WHR、AST、ALT、FBG、HbALc、TG、LDL-C、HDL-C指标的改善均优于对照组(P<0.05或P<0.01)。结论:调脂活血降糖方具有降低2型糖尿病合并非酒精性脂肪性肝病患者的血糖、减轻肝脏损害程度、改善血脂代谢异常等作用,与二甲双胍联合用药临床疗效优于单纯应用二甲双胍。 Objective:To observe the clinical effects of Tiaozhi Huoxue Jiangtang Prescription in treating type Ⅱdiabetic patients with non-alcoholic fatty liver disease.Methods:60 patients with typeⅡdiabetes combined with non-alcoholic fatty liver disease were randomly divided into treatment group and control group,30 cases in each group.Based on the diet and exercise therapy,the control group were given oral administration of metformin tablets 0.25g,3 times a day;on the basis of the treatment of control group,the treatment group received additional administration of Tiaozhi Huoxue Jiangtang Prescription,once a day.Two groups were treated for 90d to observe the clinical effects and the changes of BMI,WHR,AST,ALT,FBG,HbALc,TG,LDL-C,HDL-C before and after the treatment.Results:The total effective rates of the treatment group and the control group were respectively 93.3% and 46.7%.The difference between the two groups was statistically significant(P0.01);the improvement of indicators BMI,WHR,AST,ALT,FBG,HbALc,TG,LDL-C,HDL-C in the treatment group were better than those of the control group(P0.05 or P0.01).Conclusion:Tiaozhi Huoxue Jiangtang Prescription has the functions of lowering the blood sugar,reducing the degree of liver damage and improving the role of abnormal lipid metabolism of patients with type Ⅱ diabetes nonalcoholic fatty liver disease,the clinical effect of combination therapy with metformin is superior to that of alone applications of metformin.
作者 王玉保
出处 《河南中医》 2010年第10期974-976,共3页 Henan Traditional Chinese Medicine
关键词 2型糖尿病 非酒精性脂肪性肝病 调脂活血降糖方 二甲双胍 type Ⅱ diabetes non-alcoholic fatty liver disease Tiaozhi Huoxue Jiangtang Prescription
  • 相关文献

参考文献6

二级参考文献27

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2McCullough,AJ.Update on non-alcoholic fatty liver disease.J Clin Gastroenterol,2002,34:225- 262.
  • 3Bernal-Reyes R,Saenz-Labra A,Bernaydo-Escudero R.Prevalence of non-alcoholic steatohepatitis.Comparative study with diabetic patients. Review Gastroenterol Mexico,2000, 65: 58-62.
  • 4Luyckx FH,Lefebvre PJ,Scheen AJ,et al. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Meteb, 2000, 26:98-106.
  • 5Kaplan LM. Leptin,obesity,and liver disease.Gastroenterology, 1998, 115:997-1001.
  • 6Montague CT, Farooqi IS,Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature,1997,387:903-908.
  • 7Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 8Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 9Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 10Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.

共引文献1575

同被引文献51

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部